Adaptive Biotechnologies's total assets for Q4 2025 were $512.74M, an increase of 4.51% from the previous quarter. ADPT total liabilities were $287.74M for the fiscal quarter, a 0.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.